Article info
PDFOriginal research
Low expression of DDX5 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma
- Correspondence to Dr Kenichi Hirabayashi, Department of Pathology, Tokai University School of Medicine, Isehara, Kanagawa, Japan; kenichi.hirabayashi{at}tokai.ac.jp
Citation
Low expression of DDX5 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma
Publication history
- Received August 3, 2020
- Revised September 16, 2020
- Accepted October 6, 2020
- First published October 23, 2020.
Online issue publication
January 08, 2022
Article Versions
- Previous version (8 January 2022).
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.